Cargando…

Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response

The increase of the sedentary lifestyle and high-calorie diet have modified the etiological landscape of hepatocellular carcinoma (HCC), with a recrudescence of non-alcoholic fatty liver disease (NAFLD), especially in Western countries. The purpose of our study was to evaluate the impact of high-fat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simoes Eugénio, Mélanie, Farooq, Muhammad, Dion, Sarah, Devisme, Christelle, Raguenes-Nicol, Céline, Piquet-Pellorce, Claire, Samson, Michel, Dimanche-Boitrel, Marie-Thérèse, Le Seyec, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352283/ https://www.ncbi.nlm.nih.gov/pubmed/32521615 http://dx.doi.org/10.3390/cancers12061491

Ejemplares similares

Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
por: Farooq, Muhammad, et al.
Publicado: (2019)

Switching to Regular Diet Partially Resolves Liver Fibrosis Induced by High-Fat, High-Cholesterol Diet in Mice
por: Farooq, Muhammad, et al.
Publicado: (2022)

RIPK1 in Liver Parenchymal Cells Limits Murine Hepatitis during Acute CCl(4)-Induced Liver Injury
por: Hameed, Huma, et al.
Publicado: (2022)

RIPK1 protects hepatocytes from death in Fas-induced hepatitis
por: Filliol, Aveline, et al.
Publicado: (2017)

RIPK1 protects from TNF-α-mediated liver damage during hepatitis
por: Filliol, Aveline, et al.
Publicado: (2016)

TRIM21, a New Component of the TRAIL-Induced Endogenous Necrosome Complex
por: Simoes Eugénio, Mélanie, et al.
Publicado: (2021)

Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis
por: Vasseur, Philippe, et al.
Publicado: (2017)

A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline
por: Pelletier, Romain, et al.
Publicado: (2022)

Endogenous IL-33 Deficiency Exacerbates Liver Injury and Increases Hepatic Influx of Neutrophils in Acute Murine Viral Hepatitis
por: Carrière, Virginie, et al.
Publicado: (2017)

Toll‐like receptor‐2 exacerbates murine acute viral hepatitis
por: Bleau, Christian, et al.
Publicado: (2016)

Milk Fermented by Propionibacterium freudenreichii Induces Apoptosis of HGT-1 Human Gastric Cancer Cells
por: Cousin, Fabien J., et al.
Publicado: (2012)

The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with Leishmania donovani
por: Rostan, Octavie, et al.
Publicado: (2013)

Grundlagen der Zellbiologie
por: Boujard, Daniel, et al.
Publicado: (2014)

Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death
por: Delehouzé, Claire, et al.
Publicado: (2022)

The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer
por: Cousin, Fabien J., et al.
Publicado: (2016)

Betulin, a Newly Characterized Compound in Acacia auriculiformis Bark, Is a Multi-Target Protein Kinase Inhibitor
por: Ahmadu, Augustine A., et al.
Publicado: (2021)

Incidental finding of non-alcoholic steatohepatitis-cirrhosis
por: Adrian, Therese, et al.
Publicado: (2022)

Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells.
por: Assem, M., et al.
Publicado: (1994)

Invariant NKT Cells Drive Hepatic Cytokinic Microenvironment Favoring Efficient Granuloma Formation and Early Control of Leishmania donovani Infection
por: Robert-Gangneux, Florence, et al.
Publicado: (2012)

Interleukin-33 overexpression is associated with liver fibrosis in mice and humans
por: Marvie, Pierrick, et al.
Publicado: (2010)

Pathogenic Mouse Hepatitis Virus or Poly(I:C) Induce IL-33 in Hepatocytes in Murine Models of Hepatitis
por: Arshad, Muhammad Imran, et al.
Publicado: (2013)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis
por: Overi, Diletta, et al.
Publicado: (2020)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

The burden of nonalcoholic steatohepatitis (NASH) in the United States
por: Tapper, Elliot B., et al.
Publicado: (2023)

Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis
por: Bhardwaj, Rishi R., et al.
Publicado: (2010)

Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice exhibiting toxicant-associated steatohepatitis
por: Wahlang, Banrida, et al.
Publicado: (2021)

Endothelial dysfunction in patients with non-alcoholic steatohepatitis
por: Onal, Ibrahim Koral
Publicado: (2014)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

Conophylline inhibits non-alcoholic steatohepatitis in mice
por: Nakade, Yukiomi, et al.
Publicado: (2017)

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
por: Zhu, Bo, et al.
Publicado: (2021)

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis
por: Kim, Hyeong Geug, et al.
Publicado: (2021)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
por: Habig, Gregory, et al.
Publicado: (2021)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Mechanisms of ductular reaction in non-alcoholic steatohepatitis
por: Chen, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gsar4bqp7dpcugsoijjm7trju8